JSR Life Sciences について

私たちのことを学ぶ

JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.

JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.

Accelerating Our Life Sciences Footprint

We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.

Our Affiliates

We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.

Crown Bioscience
Contract research organization with advanced technology for precision medicine

Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.

MBL
Biomarker discovery for companion and in vitro diagnostics

KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities


JSR’s specialty life science research products include:

Amsphere A3, a protein A chromatography resin for advanced protein separation

Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use

JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.

最新の JSR Life Sciences ニュース

Crown BioscienceがIndivumed Servicesとの合併を完了

Crown Bioscience は Indivumed Services の合併を完了し、強化された医薬品開発ソリューションを世界中に提供し、Indivumed ブランドを廃止します。

Crown Bioscience Germany GmbH が CAP ISO 15189:2022 認定を継続取得

Crown Bioscience Germany GmbH が CAP ISO 15189:2022 認定を継続取得

Crown Bioscience、顧客サービスとパートナーシップにおける 卓越性で2024年フィアースCRO賞を受賞

Crown Bioscience は、革新的な医薬品開発パートナーシップへの取り組みを実証し、優れた顧客サービスが評価され 2024 Fierce CRO Award を受賞しました。

JSR Life Sciences ニュースを RSSリーダーで受け取る

またはAtom URLで手動で購読